News
RDHL
0.5000
-3.92%
-0.0204
Weekly Report: what happened at RDHL last week (0914-0918)?
Weekly Report · 6d ago
Weekly Report: what happened at RDHL last week (0907-0911)?
Weekly Report · 09/14 10:02
RedHill Biopharma Pushes for Growth Securing Rights to Ferring’s $37M Gastrointestinal Drugs Portfolio
TipRanks · 09/08 14:49
Weekly Report: what happened at RDHL last week (0831-0904)?
Weekly Report · 09/07 09:57
RedHill Sells its Talicia® H. pylori Drug Business to Apotex in $18M Deal to Fuel Growth
TipRanks · 09/01 15:41
RedHill Biopharma Inks 13-Year Global Deal for Ferring’s Rebyota and U.S. Rights to Clenpiq
TipRanks · 09/01 11:30
RedHill acquires exclusive commercialization rights to Rebyota, Clenpiq for $12M
TipRanks · 09/01 11:20
RedHill Announces Transformational Acquisition of Commercialization Rights to Ferring's Rebyota® and Clenpiq®
PR Newswire · 09/01 11:00
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 08/31 17:06
Redhill Biopharma Stock Doubles In One Session — Here's Why
Benzinga · 08/31 14:06
Why Is Penny Stock RedHill Biopharma (RDHL) Up 103% Today?
TipRanks · 08/31 13:23
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 08/31 12:06
Market-Moving News for August 31st
Benzinga · 08/31 11:38
Apotex Secures Full Ownership of Talicia in $53 Million Deal with RedHill BioPharma
Dow Jones · 08/31 11:32
RedHill announces divestment of Talicia business to Apotex Health subsidiary
TipRanks · 08/31 11:15
RedHill Biopharma divests Talicia to Apotex for $18M upfront
Seeking Alpha · 08/31 11:13
Redhill Biopharma Divests Talicia Business To Apotex Health Subsidiary For An Upfront Payment Of $18M Plus Up To An Additional $35M In Potential Sales-based Milestone Payments
Benzinga · 08/31 11:03
*RedHill Biopharma: Apotex Will Receive RedHill's 70% Interest in Talicia, Following Apotex's Prior Acquisition of Cumberland Pharmaceuticals' U.S. Branded Business >RDHL
Dow Jones · 08/31 11:03
*RedHill Biopharma: Deal Includes Additional $35M in Potential Payments Based on Worldwide Net Sales Milestones >RDHL
Dow Jones · 08/31 11:02
Weekly Report: what happened at RDHL last week (0824-0828)?
Weekly Report · 08/31 10:03
More
Webull provides a variety of real-time RDHL stock news. You can receive the latest news about Redhill Biopharm through multiple platforms. This information may help you make smarter investment decisions.
About RDHL
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204, for pulmonary nontuberculous mycobacteria (NTM) disease; opaganib (ABC294640), host-directed, SPHK2 inhibitor targeting multiple indications, RHB-107 (upamostat), an oral, host-directed serine protease inhibitor with potential for pandemic preparedness, is in late-stage development for treatment of non-hospitalized symptomatic COVID-19, and is targeting multiple other cancer and inflammatory gastrointestinal diseases; RHB-104 for Crohn's disease; and RHB-102 for chemotherapy and radiotherapy induced nausea and vomiting.